Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19-Reference-Cited by-同舟云学术

Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19

Published:2021-12-01 Issue:12 Volume:181 Page:1612
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Spyropoulos Alex C.¹²³,Goldin Mark¹²,Giannis Dimitrios¹,Diab Wassim²,Wang Janice¹²,Khanijo Sameer²,Mignatti Andrea²⁴,Gianos Eugenia²⁴,Cohen Marc⁵,Sharifova Gulru²,Lund Jeet M.⁶,Tafur Alfonso⁷⁸,Lewis Paul A.⁹,Cohoon Kevin P.¹⁰,Rahman Husneara¹¹¹,Sison Cristina P.¹²¹¹,Lesser Martin L.¹²¹¹,Ochani Kanta¹,Agrawal Nirav¹,Hsia Judith¹²¹³,Anderson Victoria E.¹²,Bonaca Marc¹²¹³,Halperin Jonathan L.¹⁴,Weitz Jeffrey I.¹⁵¹⁶¹⁷,Ohanesian Lori¹⁸,Glater Michelle¹⁸,Ho Christopher¹⁸,Iakovou Annamaria¹⁸,Ying Daniel¹⁸,Dastagir Manile¹⁸,Convissar Alex¹⁸,Aujla Seerat¹⁸,Mathew Elizabeth¹⁸,Thiyagarajan Vani¹⁸,Lewis Tricia¹⁸,Gruberg Luis¹⁸,Maccaro Paul¹⁸,Kuziw Dana¹⁸,Pandhi Bhumi¹⁸,Surguladze George¹⁸,Eapen Ashley M.¹⁸,Pantea Alexandra¹⁸,Suen Phyllis¹⁸,Flynt John¹⁸,Krzyzak Michael¹⁸,Sharma Kamal¹⁸,Steadham Amanda¹⁸,McLean Sherry L.¹⁸,Herring Karen¹⁸,Maroney Karen¹⁸,Zorriasateyn Kambiz¹⁸,Vargas Bernardo¹⁸,Durante Marisa¹⁸,Bhokary Ujala¹⁸,Pierchala Linda¹⁸,Fisher Elizabeth A.¹⁸,Oxenberg Debi L.¹⁸,Sabados Alison¹⁸,Chaudhary Omair A.¹⁸,Schultz Shelley¹⁸,Cotey Sue¹⁸,Hess Connie¹⁸,Cruse Hope¹⁸,Uy Daniel¹⁸,Sharma Sunita¹⁸,Molina Kevin¹⁸,Jagat Daliya¹⁸,Dehali Bandyopadhyay¹⁸,

Affiliation:

1. Institute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York

2. Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York

3. Department of Obstetrics and Gynecology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia

4. Department of Cardiology, Lenox Hill Hospital, Northwell Health, New York, New York

5. Department of Medicine, Newark Beth Israel Medical Center, Newark, New Jersey

6. WellSpan York Hospital, York, Pennsylvania

7. Department of Medicine, Cardiovascular Institute, NorthShore University HealthSystem, Evanston, Illinois

8. Division of Cardiology, Pritzker School of Medicine, University of Chicago, Chicago, Illinois

9. BayCare Health System, Inc, Clearwater, Florida

10. Division of Cardiovascular Medicine, Department of Medicine, Froedtert & the Medical College of Wisconsin, Milwaukee

11. Biostatistics Unit, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York

12. Colorado Prevention Center (CPC) Clinical Research, Aurora

13. Division of Cardiology, University of Colorado School of Medicine, University of Colorado, Aurora

14. Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Medical Center, New York, New York

15. Department of Medicine, McMaster University, Hamilton, Ontario, Canada

16. Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada

17. Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada

18. for the HEP-COVID Investigators

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/2785004/jamainternal_spyropoulos_2021_oi_210062_1640116408.0197.pdf

Reference31 articles.

1. Thrombosis in hospitalized patients with COVID-19 in a New York City health system.;Bilaloglu;JAMA,2020

2. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis.;Klok;Thromb Res,2020

3. Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis.;Nopp;Res Pract Thromb Haemost,2020

4. Hospitalized COVID-19 patients and venous thromboembolism: a perfect storm.;Spyropoulos;Circulation,2020

5. Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence.;Poissy;Circulation,2020

Cited by 328 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19;JACC: Advances;2024-03

2. Therapeutic-Dose Anticoagulation in Hospitalized Patients With COVID-19;JACC: Advances;2024-03

3. Effect of antiplatelet therapy after COVID-19 diagnosis: A systematic review with meta-analysis and trial sequential analysis;PLOS ONE;2024-02-01

4. Uncertainties about the roles of anticoagulation and microclots in post-acute sequelae of SARS-CoV-2 infection—response to the letter by Kell et al.;Journal of Thrombosis and Haemostasis;2024-02

5. Presence of procoagulant peripheral blood mononuclear cells in severe COVID-19 patients relate to ventilation perfusion mismatch and precede pulmonary embolism;Journal of Critical Care;2024-02